From the rising cost of providing data from clinical trials to bringing new medical devices to market, we today announce a global support program. This global support program is specifically for medical technology start-ups. This will enable the start-ups to slash the cost of clinical trials and bring new devices to market faster. Altogether, complying with the European Union’s Medical Device Regulation (MDR).
MedTech start-ups and small MedTech organizations can apply for this special start-up offer via the Offer site. The offer includes a 50% discount on all SMART-TRIAL license services for up to 12 months. The services included are access to the SMART-TRIAL platform, randomization functionality, safety data reporting, IoT data integration, and more. The discount is dependent upon organizational parameters such as size and age.
"MedTech start-ups are revolutionizing the medical device industry in numerous small and not-so-small ways. However, the costs of bringing new device technology to market are now proving prohibitive to most MedTech start-ups. This SMART-TRIAL support program will help them overcome the hurdles in providing clinical evidence to the Regulators at less cost"
says Pall Johannesson, MEDEI’s CEO
Johannesson points out that while FDA regulations are lowering requirements for some medical market approvals, the EU is heightening its regulations. This means access to the EU for new medical technology products is proving more difficult, time-consuming and costly. More clinical evidence is now required to be collected and managed by MedTech companies.
"With higher quality data management, start-ups will be more likely to succeed in today’s market because they will have data that can prove device efficacy, safety, and usability. This will also prove invaluable in further product development, funding, market access, and marketing"
Check the link to see if you Qualify for the MedTech Start-Up Offer
ANDVisit the website to learn about the features SMART-TRIALFor further information on the Offer please contact:Jón Ingi BergsteinssonMEDEI ApSVice President for Global Business DevelopmentTel: +45 42 70 70 03Email: email@example.com